PALATIN TECHNOLOGIES INC
PTN$26M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaCRANBURY
Drugs in Pipeline
5
Phase 3 Programs
2
Upcoming Catalysts
1
Next Catalyst
Aug 12, 2026
7wMarket Overview
Stock performance and key metrics
PTN News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
Bremelanotide
Kidney Disease
Vehicle Ophthalmic Solution
Dry Eye
tirzepatide
Obesity
PL3994
Hypertension
PL8177
Ulcerative Colitis
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Bremelanotide | Phase 3 | Kidney Disease | - | - |
Vehicle Ophthalmic Solution | Phase 3 | Dry Eye | - | - |
tirzepatide | Phase 2 | Obesity | - | - |
PL3994 | Phase 2 | Hypertension | - | - |
PL8177 | Phase 2 | Ulcerative Colitis | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply